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There is recent evidence to suggest that im-
mune functions may be disordered in patients
with Parkinson’s disease (PD). Auto-antibodies
reacting with neural structures have been found
in a substantial proportion of these patients.
However, it is possible that the presence of auto-
antibodies may reflect a deregulation of hypo-
thalamic-mediated immune modulation. The
hypothalamus has been shown to play a central
role in mediation and integration of both
humoral and cell-mediated immune response
/1,2/. The purpose of our study was to address
the rate of T cells (CD2+), HelperBnducer T
cells (CD4+), Suppressor/Cytotoxic T cells
(CD8+), HLA DR+ cells and the presence of
interleukin-2 receptor (CD25+) in the peri-
pheral blood (PB) and CSF of patients with PD
by an immunocytochemical method that permits
both morphological evaluation and immunologi-
cal classification of cells.
Control CSF was taken from (orthopedic and
proctologic) patients submitting to surgical
procedures using spinal anaesthesia. PD CSF
and PB were taken from 11 patients graded as
III-IV on the Hohen and Yahr Rating Scale.
Multispot slides, with 21 spots separated by
water-repellent dimethylpolysiloxane were used
for cell attachment, and coated with poly-L-
lysine. Ten microliters of cell suspensions were
added to each spot and sequentially incubated in
the appropriate immunologic reagents. The cells
were stained for enzyme activity (Streptavidin/
Biotin-HRP-System).
Significant amounts of CD25+ lymphocytes
were usually present in the CSF of PD patients
and controls. However, CSF from PD patients
showed higher levels of CD25+, HLA-DR+ and
CD4+ cells. Taking into account that these
patients are in later stages of the disease, not
only had degeneration of neurons in substantia
nigra and other pigmented brainstem nuclei
occurred, but degeneration was also seen in
hypothalamus and sympathetic ganglia, i.e. in
the neural structures presently known to be
involved in immune regulation. Surface marker
levels, except CD8+ cells, were significantly
higher in CSF than in PB of PD patients, par-
ticularly CD4+ and CD25+ cells (Figure).
These results suggest selective cell crossing
through the blood-brain barrier for these popu-
lations that show activated markers.
In summary, (i) in normal CSF 90% of cells
are T lymphocytes; (ii) a high ratio of CSF
lymphocytes from normal controls are CD25+
cells and (iii) significant differences were found
in the percentage of CD4+, CD25+ and HLA-
DR+ cells between CSF from PD patients and
normal controls, as well as in the percentage of
CD2+, CD4+, CD25+ and HLA-DR+ cells be-
tween CSF and PB from PD patients. These
findings suggest that disordered neural-immune
regulation should be considered as a potential
cause of immune abnormalities occurring in PD
patients.
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